NanHua Bio-medicine Co., Ltd (000504.SZ)
CNY 9.85
(0.82%)
CNY 9.85
(0.82%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 36.27 Million | 166.38 Million | 107.09 Million | -207.22 Million | 14.52 Million | -15.18 Million |
| Net Income | -46.77 Million | -29.76 Million | -33.1 Million | 14.63 Million | 18.26 Million | -38.04 Million |
| Depreciation & Amortization | 6.34 Million | 6.21 Million | 6.87 Million | 3.35 Million | 5.71 Million | 5.04 Million |
| Deferred income taxes | -673.21 Thousand | 523.82 Thousand | -625.52 Thousand | -1.19 Million | -692.77 Thousand | 729.75 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 28.94 Million | 141.55 Million | 91.79 Million | -230.97 Million | 10.02 Million | 2.86 Million |
| Other non-cash items | 20.22 Million | 48.37 Million | 41.53 Million | 5.76 Million | -19.48 Million | 14.95 Million |
| Investing Cash Flow | 12.75 Million | -16.11 Million | -30.14 Million | 8.28 Million | 81.25 Million | -23.74 Million |
| Investments in PPE | -5.91 Million | -16.94 Million | -31.96 Million | -4.46 Million | -2.57 Million | -9.29 Million |
| Acquisitions | 18.82 Million | -9.38 Million | 74.14 Thousand | 4.47 Million | 81.5 Million | -21.76 Million |
| Investment purchases | -321.9 Million | -248.49 Million | -125.3 Million | -105.51 Million | -39.76 Million | -2295.00 |
| Sales/Maturities of investments | 322.85 Million | 248.98 Million | 125.44 Million | 118.25 Million | 42.59 Million | 858.79 Thousand |
| Other Investing Activities | 18.67 Million | 9.71 Million | 1.59 Million | -4.46 Million | -505.83 Thousand | 6.46 Million |
| Financing Cash Flow | 226.63 Million | -85.15 Million | 9.01 Million | 196.58 Million | -85.78 Million | -69.31 Million |
| Debt repayment | -34.99 Million | -44.99 Million | -36 Million | -50 Million | -179 Million | -141 Million |
| Dividends payments | -2.28 Million | -2.4 Million | -2.11 Million | -1.12 Million | -12.41 Million | -9.13 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 264.83 Million | -37.75 Million | 47.13 Million | 247.7 Million | 105.62 Million | 80.82 Million |
| Accounts receivables | 9.83 Million | 135.21 Million | 47.23 Million | -306.89 Million | -15.11 Million | 1.7 Million |
| Accounts payables | 25.95 Million | 996.62 Thousand | 40.88 Million | 73.41 Million | 22.87 Million | 1.84 Million |
| Inventory | -6.17 Million | 4.82 Million | 4.29 Million | 3.69 Million | 2.95 Million | -1.41 Million |
| Other working capital | 25.28 Million | 523.82 Thousand | -625.52 Thousand | -1.19 Million | -692.77 Thousand | 4.28 Million |
| Cash at beginning of period | 218.11 Million | 153 Million | 67.03 Million | 69.39 Million | 59.01 Million | 166.57 Million |
| Cash at end of period | 493.78 Million | 218.11 Million | 153 Million | 67.03 Million | 69.39 Million | 59.01 Million |
| Capital Expenditure | -5.91 Million | -16.94 Million | -31.96 Million | -4.46 Million | -2.57 Million | -9.29 Million |
| Effect of forex changes on cash | 45.35 | 226.14 | 57.29 | 173.30 | 390.79 Thousand | 683.29 Thousand |
| Net cash flow / Change in cash | 275.66 Million | 65.11 Million | 85.96 Million | -2.35 Million | 10.37 Million | -107.56 Million |
| Free Cash Flow | 30.35 Million | 149.43 Million | 75.13 Million | -211.68 Million | 11.94 Million | -24.48 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -17.92 Thousand | -5.62 Million | -2.77 Million | -28.65 Million | -46.77 Million | 9.45 Million |
| Depreciation & Amortization | - | 3.95 Million | 3.95 Million | 6.34 Million | 6.34 Million | -3.2 Million |
| Deferred income taxes | - | - | - | - | -673.21 Thousand | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -22.19 Million | - | 3.65 Million | 28.94 Million | 241.49 Thousand |
| Other non-cash items | 6.78 Million | 14.7 Million | 1.26 Million | 34.51 Million | 20.22 Million | 4.81 Million |
| Investing Cash Flow | -4.39 Million | 17.69 Million | -118.82 Million | 252.73 Thousand | 12.75 Million | 13.93 Million |
| Investments in PPE | -12.64 Million | -118.41 Thousand | -3.28 Million | 2.22 Million | -5.91 Million | -6.1 Million |
| Acquisitions | 4.6 Million | - | - | -2.12 Million | 18.82 Million | - |
| Investment purchases | -13 Million | -76 Million | -228.1 Million | 81.6 Million | -321.9 Million | -89.5 Million |
| Sales/Maturities of investments | 16.64 Million | 93.81 Million | 112.56 Million | -80.34 Million | 322.85 Million | 88.6 Million |
| Other Investing Activities | 4.6 Million | 17.81 Million | -115.53 Million | -1.97 Million | 18.67 Million | 20.94 Million |
| Financing Cash Flow | 9.52 Million | -29.14 Million | -160.85 Million | 259.44 Million | 226.63 Million | -24.38 Million |
| Debt repayment | -10 Million | -28 Million | - | -9.96 Million | -34.99 Million | -30.03 Million |
| Dividends payments | - | -121.91 Thousand | -4.68 Million | -3.21 Million | -2.28 Million | -3.59 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -471.07 Thousand | -1.02 Million | -156.17 Million | 267.1 Million | 264.83 Million | 9.24 Million |
| Accounts receivables | - | -14.05 Million | - | 9.83 Million | 9.83 Million | -1.09 Million |
| Accounts payables | - | - | - | - | 25.95 Million | - |
| Inventory | - | -8.13 Million | - | -6.17 Million | -6.17 Million | 1.33 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 204.5 Million | 212.59 Million | 493.78 Million | 218.23 Million | 218.11 Million | 217.47 Million |
| Cash at end of period | 214.7 Million | 204.5 Million | 212.59 Million | 493.78 Million | 493.78 Million | 218.23 Million |
| Capital Expenditure | -12.64 Million | -118.41 Thousand | -3.28 Million | 2.22 Million | -5.91 Million | -6.1 Million |
| Effect of forex changes on cash | - | 16.00 | - | -54.95 | 45.35 | -100.62 Thousand |
| Net cash flow / Change in cash | 10.19 Million | -8.08 Million | -281.18 Million | 275.55 Million | 275.66 Million | 752.6 Thousand |
| Free Cash Flow | -5.88 Million | 5 Million | -4.79 Million | 18.07 Million | 30.35 Million | 5.19 Million |
SG
RSF
BHPA
NEXOF
UANG
TKAYF